What does CUSIP 04351P101 represent in this 13F holders report?

CUSIP 04351P101 is the security identifier for ASND - Ascendis Pharma A/S - Common Stock used to aggregate holder disclosures.

How many institutions held ASND - Ascendis Pharma A/S - Common Stock in Q2 2023?

156 institutional investors reported ASND - Ascendis Pharma A/S - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Ascendis Pharma A/S - Common Stock (ASND)

CUSIP: 04351P101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 61,152,075
Total 13F shares: 61,039,136
Share change: +48,558
Total reported value: $5,447,708,812
Put/Call ratio: 63%
Price per share: $89.25
Number of holders: 156
Value change: -$42,606,636
Number of buys: 85
Number of sells: 83

Quarterly Holders Quick Answers

What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 04351P101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	11%	6,957,179	$745,948,732	—	31 Mar 2023	13F
Artisan Partners Limited Partnership	13F	Company	11%	6,844,741	$733,893,130	—	31 Mar 2023	13F
FMR LLC	13F	Company	8.4%	5,152,165	$552,415,131	—	31 Mar 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	5.8%	3,532,830	$378,818,407	—	31 Mar 2023	13F
T. Rowe Price Investment Management, Inc.	13F	Company	5.7%	3,473,466	$372,426,000	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	5.5%	3,369,943	$361,326,000	—	31 Mar 2023	13F
Avoro Capital Advisors LLC	13F	Company	5.4%	3,325,000	$356,506,500	—	31 Mar 2023	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	5.1%	3,146,126	$337,327,617	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	4.8%	2,933,792	$314,561,178	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	4.2%	2,548,145	$273,212,107	—	31 Mar 2023	13F
Capital International Investors	13F	Company	3.3%	1,989,106	$213,271,945	—	31 Mar 2023	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	2.2%	1,357,574	$145,559,084	—	31 Mar 2023	13F
FRANKLIN RESOURCES INC	13F	Company	2.2%	1,345,904	$144,307,794	—	31 Mar 2023	13F
TimesSquare Capital Management, LLC	13F	Company	1.4%	852,080	$91,360,000	—	31 Mar 2023	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.3%	782,840	$83,936,105	—	31 Mar 2023	13F
Point72 Asset Management, L.P.	13F	Company	1.3%	771,110	$82,678,414	—	31 Mar 2023	13F
Sofinnova Investments, Inc.	13F	Company	1.2%	754,032	$80,847,311	—	31 Mar 2023	13F
PUTNAM INVESTMENTS LLC	13F	Company	1.2%	740,862	$79,435,224	—	31 Mar 2023	13F
Spyglass Capital Management LLC	13F	Company	1.2%	713,966	$76,551,435	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	1.1%	646,560	$69,324,163	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.84%	515,058	$55,224,519	—	31 Mar 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.82%	500,000	$53,610,000	—	31 Mar 2023	13F
SEI INVESTMENTS CO	13F	Company	0.78%	476,021	$51,038,950	—	31 Mar 2023	13F
BROWN ADVISORY INC	13F	Company	0.76%	466,372	$50,004,452	—	31 Mar 2023	13F
Rock Springs Capital Management LP	13F	Company	0.7%	425,500	$45,622,110	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.62%	381,099	$40,861,436	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.6%	365,488	$39,187,623	—	31 Mar 2023	13F
Paradigm Biocapital Advisors LP	13F	Company	0.57%	350,866	$37,619,853	—	31 Mar 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.58%	356,637	$36,891,462	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.5%	304,796	$32,680,227	—	31 Mar 2023	13F
Nicholas Investment Partners, LP	13F	Company	0.41%	251,387	$26,953,714	—	31 Mar 2023	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.41%	248,521	$26,646,422	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.4%	245,419	$26,313,779	—	31 Mar 2023	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.39%	240,215	$25,755,849	—	31 Mar 2023	13F
ARS Investment Partners, LLC	13F	Company	0.39%	239,038	$25,629,654	—	31 Mar 2023	13F
TD ASSET MANAGEMENT INC	13F	Company	0.39%	236,194	$25,324,721	—	31 Mar 2023	13F
S.c.a. Candriam	13F	Individual	0.41%	250,375	$24,709,105	—	31 Mar 2023	13F
PFM Health Sciences, LP	13F	Company	0.33%	202,115	$21,670,770	—	31 Mar 2023	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.29%	180,234	$19,324,689	—	31 Mar 2023	13F
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC	13F	Company	0.28%	169,693	$18,194,483	—	31 Mar 2023	13F
Finepoint Capital LP	13F	Company	0.26%	156,072	$16,734,040	—	31 Mar 2023	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.25%	154,928	$16,611,345	—	31 Mar 2023	13F
Logos Global Management LP	13F	Company	0.25%	150,000	$16,083,000	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.23%	139,216	$14,926,740	—	31 Mar 2023	13F
DAFNA Capital Management LLC	13F	Company	0.22%	135,212	$14,497,431	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.22%	133,218	$14,283,635	—	31 Mar 2023	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.21%	127,116	$13,629,000	—	31 Mar 2023	13F
Tekla Capital Management LLC	13F	Company	0.2%	123,791	$13,272,871	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.2%	121,002	$12,973,835	—	31 Mar 2023	13F
Ghost Tree Capital, LLC	13F	Company	0.18%	110,000	$11,794,000	—	31 Mar 2023	13F

Institutional Holders of Ascendis Pharma A/S - Common Stock (ASND) as of Q2 2023

As of 30 Jun 2023, Ascendis Pharma A/S - Common Stock (ASND) was held by 156 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,039,136 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Artisan Partners Limited Partnership, FMR LLC, T. Rowe Price Investment Management, Inc., JANUS HENDERSON GROUP PLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, and Capital International Investors. This page lists 156 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

160

Q2 2023 holders

156

Holder diff

-4

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.